- NEWS
Researchers have identified a neural biomarker of compulsive food cravings, and showed that it is suppressed by the weight-loss drug Mounjaro.
The obesity drug tirzepatide, sold as Mounjaro or Zepbound, can suppress patterns of brain activity associated with food cravings, a study suggests. Researchers measured the changing electrical signals in the brain of a person with severe obesity who had experienced persistent ‘food noise’ — intrusive, compulsive thoughts about eating — shortly after the individual began taking the medication.
Nature 647, 828-829 (2025)
doi: https://doi.org/10.1038/d41586-025-03766-2
References
Related Articles
-
Dozens of new obesity drugs are coming: these are the ones to watch
-
How blockbuster obesity drugs create a full feeling — even before one bite of food
How to keep weight off after obesity drugs
Obesity drugs: huge study identifies new health risks
Why do obesity drugs seem to treat so many other ailments?
Subjects
Latest on:
Jobs
-
-
-
-
Assistant Professor in Metabolism Research
The Morgridge Institute for Research, in partnership with the University of Wisconsin-Madison, seeks a joint tenure track assistant professor.
Madison, Wisconsin
Jill Walder
-